Efficacy and Safety of Bufei Jiedu Granules in Treating Multidrug-Resistant Pulmonary Tuberculosis: A Multi-center, Double-Blinded and Randomized Controlled Trial.
Shao-Yan ZhangLei QiuShun-Xian ZhangHe-Ping XiaoNai-Hui ChuXia ZhangHui-Qiang ZhangPei-Yong ZhengHui-Yong ZhangZhen-Hui LuPublished in: Chinese journal of integrative medicine (2024)
Supplementing BFJD Granules with the long-course chemotherapy regimen significantly increased the cure rate and cavity closure rates, and rapidly improved QoL of patients with MDR-PTB (Registration No. ChiCTR-TRC-12002850).
Keyphrases
- pulmonary tuberculosis
- multidrug resistant
- randomized controlled trial
- mycobacterium tuberculosis
- drug resistant
- gram negative
- acinetobacter baumannii
- study protocol
- klebsiella pneumoniae
- locally advanced
- squamous cell carcinoma
- clinical trial
- chemotherapy induced
- cystic fibrosis
- pseudomonas aeruginosa
- meta analyses